113 related articles for article (PubMed ID: 3229054)
1. Magnetic resonance imaging in clinical cervical cancer: pretherapeutic tumour volumetry.
Hofmann HM; Ebner F; Haas J; Einspieler R; Justich E; Lahousen M; Pickel H; Burghardt E
Baillieres Clin Obstet Gynaecol; 1988 Dec; 2(4):789-802. PubMed ID: 3229054
[TBL] [Abstract][Full Text] [Related]
2. The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients.
Jung DC; Ju W; Choi HJ; Kang S; Park S; Yoo CW; Park SY
Eur J Cancer; 2008 Jul; 44(11):1524-8. PubMed ID: 18573655
[TBL] [Abstract][Full Text] [Related]
3. Results of surgical treatment of 1028 cervical cancers studied with volumetry.
Burghardt E; Baltzer J; Tulusan AH; Haas J
Cancer; 1992 Aug; 70(3):648-55. PubMed ID: 1623479
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging in cervical cancer: a basis for objective classification.
Burghardt E; Hofmann HM; Ebner F; Haas J; Tamussino K; Justich E
Gynecol Oncol; 1989 Apr; 33(1):61-7. PubMed ID: 2703168
[TBL] [Abstract][Full Text] [Related]
5. Objective results of the operative treatment of cervical cancer.
Burghardt E; Pickel H; Haas J; Lahousen M
Baillieres Clin Obstet Gynaecol; 1988 Dec; 2(4):987-95. PubMed ID: 3229067
[TBL] [Abstract][Full Text] [Related]
6. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
7. Estimation of tumor volume in cervical cancer by magnetic resonance imaging.
Narayan K; McKenzie A; Fisher R; Susil B; Jobling T; Bernshaw D
Am J Clin Oncol; 2003 Oct; 26(5):e163-8. PubMed ID: 14528092
[TBL] [Abstract][Full Text] [Related]
8. Value of magnetic resonance imaging with an endovaginal receiver coil in the pre-operative assessment of Stage I and IIa cervical neoplasia.
deSouza NM; McIndoe GA; Soutter WP; Krausz T; Chui KM; Hughes C; Mason WP
Br J Obstet Gynaecol; 1998 May; 105(5):500-7. PubMed ID: 9637118
[TBL] [Abstract][Full Text] [Related]
9. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
[TBL] [Abstract][Full Text] [Related]
10. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls.
Balcacer P; Shergill A; Litkouhi B
Abdom Radiol (NY); 2019 Jul; 44(7):2557-2571. PubMed ID: 30903231
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in the measurement of clinical stage IB cervical carcinoma.
Innocenti P; Fiumicelli D; Agostini S; Savino L; Taddei G; Santoni R; Villari N
Eur J Radiol; 1996 Nov; 23(3):222-7. PubMed ID: 9003929
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].
Goudy G; Stoeckle E; Thomas L; Kind M; Guyon F; Brouste V; Floquet A
Bull Cancer; 2009 Jun; 96(6):685-94. PubMed ID: 19467961
[TBL] [Abstract][Full Text] [Related]
13. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
[TBL] [Abstract][Full Text] [Related]
14. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
15. Identifying selection criteria for non-radical hysterectomy in FIGO stage IB cervical cancer.
Kasamatsu T; Ishikawa M; Murakami N; Okada S; Ikeda SI; Kato T; Itami J
J Obstet Gynaecol Res; 2019 Apr; 45(4):882-891. PubMed ID: 30672089
[TBL] [Abstract][Full Text] [Related]
16. [Stage I and II cervical carcinoma. Study with magnetic resonance and transrectal echography].
Tipaldi L; Squillaci E; Cecconi L; Lombardi A; Marsella A; Vincenzoni C; Crecco M; Squillaci S
Radiol Med; 1991 May; 81(5):666-70. PubMed ID: 2057594
[TBL] [Abstract][Full Text] [Related]
17. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
Gynecol Oncol; 2016 Oct; 143(1):77-82. PubMed ID: 27423377
[TBL] [Abstract][Full Text] [Related]
20. Stage IB cervical carcinoma: comparison of clinical, MR, and pathologic staging.
Rubens D; Thornbury JR; Angel C; Stoler MH; Weiss SL; Lerner RM; Beecham J
AJR Am J Roentgenol; 1988 Jan; 150(1):135-8. PubMed ID: 3257111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
